Drug · DIN 02223740
NORPROLAC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 2, 2021; first marketed December 29, 2004.
- Drug Identification Number (DIN)
- 02223740
- Company (DIN owner)
- Ferring Inc.North York, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Quinagolide G02CB04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) | 0.025 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 15, 2004: NOC 153New Drug Submission (NDS) · Manufacturer name change
- June 25, 1996: NOC 4606New Drug Submission (NDS)
Other DINs named NORPROLAC
- DIN 02223759 · Cancelled Post Market
- DIN 02223767 · Cancelled Post Market
- DIN 02223775 · Cancelled Post Market